Literature DB >> 33174965

Tuberculosis and coronavirus disease 2019 coinfection.

Daniel Oliveira Pinheiro1, Mariana Santos Leite Pessoa1, Carla Franco Costa Lima1, Jorge Luis Bezerra Holanda1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33174965      PMCID: PMC7670739          DOI: 10.1590/0037-8682-0671-2020

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


× No keyword cloud information.
Little is known about the relationship between coronavirus disease 2019 (COVID-19) and tuberculosis (TB). Recent studies have indicated that individuals with either latent or active TB may be more susceptible to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the progression of the disease caused by this virus may be faster and more severe than in patients without TB . Although these cases have rarely been reported in current literature , studies have indicated that the isolation of TB cases can be an important measure to minimize the occurrence of severe cases of COVID-19 and associated hospitalizations . A 68-year-old male patient, who was diabetic and hypertensive and had chronic liver disease secondary to schistosomiasis, sought medical assistance, presented with dyspnea, fever, and cough for 1 week and was diagnosed with SARS-CoV-2 infection via the immunochromatographic solorological rapid test. Computed tomography (CT) of the chest showed changes suggestive of bronchogenic dissemination of the infection, providing a diagnostic hypothesis of an infectious/inflammatory process of granulomatous etiology (Figure 1 and Figure 2). Discrete ground-glass opacities were also noted, suggestive of an associated viral infection (Figure 3).
FIGURE 1:

Chest CT in lung window, coronal (A) and axial (B) slices, show multiple centrilobular opacities, such as small nodules and a “tree-in-bud” pattern, with areas of confluence of consolidating opacities (arrows), affecting the right lung. In the left lung, opacities with ground-glass attenuation are observed, notably peripherally, with associated fine reticular opacities.

FIGURE 2:

Chest CT in lung window, coronal (A) and axial (B) slices, show multiple centrilobular opacities, such as small nodules and a “tree-in-bud” pattern, with areas of confluence of consolidating opacities, some with areas of cavitation in the upper right lobe (arrows).

FIGURE 3:

An axial slice chest CT in lung window shows multiple centrilobular opacities, such as small nodules and a “tree-in-bud” pattern, with areas of confluence of consolidating opacities, affecting the right lung. In the left lung, opacities with ground-glass attenuation are observed, notably peripherally (arrows), with associated discreet reticular opacities.

Special attention was given to the risk of coinfection with TB, given that Brazil has an extensive number of TB cases and is currently one of the epicenters of the COVID-19 pandemic. Thus, GeneXpert MTB/RIF was performed, which presented a positive result for sensitivity to rifampicin as well as positive Acid-Alcohol Resistant Bacillus (BAAR) results in the three sputum samples acquired. The patient was referred for specific isolation during his hospitalization, with a coinfection diagnosis of SARS-CoV-2 and Mycobacterium tuberculosis.
  2 in total

1.  Tuberculosis and coronavirus: what do we know?

Authors:  Ethel Leonor Noia Maciel; Etereldes Gonçalves Júnior; Margareth Maria Pretti Dalcolmo
Journal:  Epidemiol Serv Saude       Date:  2020-04-09

2.  COVID-19 in tuberculosis patients: A report of three cases.

Authors:  Guiqing He; Jing Wu; Jichan Shi; Jianyi Dai; Michelle Gamber; Xiangao Jiang; Wenjie Sun; Jing Cai
Journal:  J Med Virol       Date:  2020-08-02       Impact factor: 20.693

  2 in total
  4 in total

Review 1.  Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review.

Authors:  Maryam Koupaei; Adel Naimi; Narges Moafi; Paria Mohammadi; Faezeh Sadat Tabatabaei; Soroosh Ghazizadeh; Mohsen Heidary; Saeed Khoshnood
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 2.  Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review.

Authors:  Narjess Bostanghadiri; Faramarz Masjedian Jazi; Shabnam Razavi; Lanfranco Fattorini; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

3.  Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).

Authors:  Quan Wang; Shasha Guo; Xiaolin Wei; Quanfang Dong; Ning Xu; Hui Li; Jie Zhao; Qiang Sun
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

4.  COVID-19 and Pulmonary Tuberculosis Coinfection in a Moroccan Patient with Pulmonary Embolism: A Case Report and Literature Review.

Authors:  Imane Zouaki; Zakaria Chahbi; Mohamed Raiteb; Mohamed Zyani
Journal:  Case Rep Infect Dis       Date:  2022-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.